Eli Lilly and Company (LLY) Is Going To Be A “Trillion-Dollar Market Cap,” Says Jim Cramer

Eli Lilly and Company (NYSE:LLY) is one of the Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 Stocks.

Eli Lilly and Company (NYSE:LLY) is one of the most frequently discussed stocks on Cramer’s morning show. He is a fan of the firm not only due to its lead in the weight loss market but also due to its drug pipeline. During his earlier appearances, Cramer has commented on Eli Lilly and Company (NYSE:LLY)’s plans to establish manufacturing facilities for its products and its plan to introduce a weight loss pill. This time around, he commented on Eli Lilly and Company (NYSE:LLY) in the context of Novo Nordisk and activist fund Parvus taking a stake in Novo:

“[On activist fund Parvus building a stake in Novo] How could they be so far behind? You know they were first, they were first mover. And then Lilly came along, Lilly by the way, still a great stock. But maybe this is going to shake up Novo.

“How about better science?. . . Because they fell behind Lilly!

[LLY]”David Ricks, if you spend time with him, has a view, of what should be done, that ends with the pill that you take every day, no shot . . but everyone’s thinking that he doesn’t have anything in the hopper. He’s got heart coming up, he’s going to have Alzheimer’s coming up, oh buy.

“It’s going be a trillion-dollar market cap, Ken Langone told me that. He’s one of the largest investors in Lilly. He knows.

“Oh my god I think that the heart failure stuff that’s coming out, I think that the blood pressure stuff that’s coming out, will they talk about liquor? I think that they don’t want to, but the craving of liquor is suppressed gambling is suppressed, biting nails is suppressed! Well, I’m just saying. But there’s going to be, I think even dementia in the end.”

In his previous remarks about Eli Lilly and Company (NYSE:LLY), Cramer discussed weight loss drugs:

“I want you to buy more… The reason why you want to buy it is because there was definitive data that came out last night about Novo Nordisk not being anywhere near as good as Eli Lilly when it comes to weight loss, which is what a lot of people are in the GLP for. And it was not reflected because the things were so crazed because of what the president announced. I think the stock could be up a hundred points when people realize, wait a second, it is definitively better than Novo. I would buy Eli Lilly hand over fist.”

Eli Lilly and Company (LLY) Is Going To Be A "Trillion-Dollar Market Cap," Says Jim Cramer

An array of pharmaceutical pills with the company’s logo on the bottle.

While we acknowledge the potential of LLY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. This article is originally published at Insider Monkey.